Among the diverse forms of genetic cardiomyopathy, ATTR-CM, hypertrophic cardiomyopathy (HCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC) have garnered significant attention because of their high prevalence, well-defined genetic basis, and feasibility of gene-targeted therapies
Thats why most people on these plans either pay the full retail price (often $1,000+ per month) or go without
Seth Gold, Louisianas Medicaid director, said at the legislative hearing on Boudreauxs bill the annual treatment for one patient costs around $16,000, and around 145,000 Medicaid enrollees would meet the requirements laid out in the bill to receive the medication
Third, the large sample size in the propensity-matched analyses resulted in narrower CIs, demonstrating higher precision